Skip to main
ALAB
ALAB logo

ALAB Stock Forecast & Price Target

ALAB Analyst Ratings

Based on 17 analyst ratings
Buy
Strong Buy 41%
Buy 41%
Hold 18%
Sell 0%
Strong Sell 0%

Bulls say

Astera Labs Inc. demonstrated strong financial performance, with significant revenue growth and improved gross margins that outpaced increased operating expenses. Driven by a faster-than-expected build-out of AI infrastructure, the company is experiencing better-than-anticipated growth in server shipments and demand for its PCIe Gen 6 products, which accounted for over 20% of revenue in the third quarter of 2025. The company's guidance for the fourth quarter projects revenue of $249 million, reflecting an 8% quarter-over-quarter and a remarkable 76.5% year-over-year increase, underscoring its position as one of the fastest-growing entities within the semiconductor industry, alongside industry-leading margins.

Bears say

Astera Labs Inc's revenue growth is closely tied to the pace of data center infrastructure spending, making it vulnerable to potential macroeconomic slowdowns in capital investment. Additionally, while the company's non-GAAP operating expenses for the quarter were reported at $70.7 million, this figure fell below the analyst estimate of $74.0 million, suggesting operational challenges. These factors contribute to a concerning outlook regarding the company's ability to meet growth expectations amidst a potentially constrained investment climate.

ALAB has been analyzed by 17 analysts, with a consensus rating of Buy. 41% of analysts recommend a Strong Buy, 41% recommend Buy, 18% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Astera Labs Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Astera Labs Inc (ALAB) Forecast

Analysts have given ALAB a Buy based on their latest research and market trends.

According to 17 analysts, ALAB has a Buy consensus rating as of Dec 10, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $185.71, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $185.71, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Astera Labs Inc (ALAB)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.